Dr. James Gulley is an internationally recognized expert in immunotherapy for cancer. He serves within the Center for Cancer Research (CCR) of the National Cancer Institute as Co-Director of the Center for Immuno-Oncology, the Clinical Director, NCI and the Acting Co-Director of the CCR. He has been an investigator on over 200 trials and has been instrumental in the clinical development of multiple immunotherapeutic agents and has led multiple first-in-human immunotherapy studies through phase 3 clinical trials.

Dr. Gulley is the President of SITC. He serves on many national and NIH boards and committees. He has authored over 350 scientific papers or chapters which have been cited over 30,000 times. He has had multiple awards including the 2010 Presidential Early Career Award for Scientists and Engineers, the highest award bestowed by the US President on investigators early in their careers. He also was awarded the 2018 Hubert H. Humphrey Award for Service to America.